Zacks Investment Research upgraded shares of Senomyx (NASDAQ:SNMX) from a sell rating to a hold rating in a research note published on Friday.
According to Zacks, “Senomyx is using proprietary taste receptor technologies to discover and develop novel flavor ingredients. These include new flavors such as Savory Flavors and Cooling Flavors, as well as flavor modulators such as Bitter Blockers and enhancers of Sweet and Salt tastes. Senomyx is also engaged in a new effort to discover and develop natural high-potency sweeteners. The Company has product discovery and development collaborations with global food, beverage, and ingredient supply companies, some of which are currently marketing products that contain Senomyx’s flavor ingredients. “
Separately, ValuEngine cut Senomyx from a sell rating to a strong sell rating in a research report on Friday, December 1st.
Senomyx (NASDAQ:SNMX) traded down $0.05 during mid-day trading on Friday, hitting $1.39. The stock had a trading volume of 147,787 shares, compared to its average volume of 125,900. The firm has a market capitalization of $66.42, a PE ratio of -5.35 and a beta of 1.39. Senomyx has a 52 week low of $0.56 and a 52 week high of $1.71.
Senomyx (NASDAQ:SNMX) last posted its quarterly earnings data on Thursday, November 2nd. The specialty chemicals company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.02. The company had revenue of $5.06 million during the quarter. Senomyx had a negative return on equity of 93.36% and a negative net margin of 65.11%. equities analysts predict that Senomyx will post -0.26 EPS for the current year.
An institutional investor recently raised its position in Senomyx stock. Algert Global LLC increased its stake in shares of Senomyx Inc. (NASDAQ:SNMX) by 14.7% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 359,788 shares of the specialty chemicals company’s stock after acquiring an additional 46,000 shares during the period. Algert Global LLC owned about 0.75% of Senomyx worth $218,000 as of its most recent filing with the SEC. 26.76% of the stock is owned by institutional investors.
TRADEMARK VIOLATION WARNING: This report was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this report on another website, it was illegally stolen and reposted in violation of United States and international trademark and copyright laws. The legal version of this report can be read at https://www.dispatchtribunal.com/2018/01/08/senomyx-snmx-upgraded-at-zacks-investment-research.html.
Senomyx Company Profile
Senomyx, Inc is focused on using taste receptor technologies to discover, develop and commercialize flavor ingredients for the packaged food, beverage and ingredient supply industries. The Company operates through development and commercialization of flavor ingredients segment. It is engaged in the discovery, development and/or commercialization of flavor ingredients through over five programs.
Get a free copy of the Zacks research report on Senomyx (SNMX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Senomyx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senomyx and related companies with MarketBeat.com's FREE daily email newsletter.